Background: Rheumatoid arthritis (RA) is a severe chronic immune mediated inflammatory disease that has been shown to be associated with human leukocyte antigen (HLA) loci. The transporter associated with antigen processing 2 (TAP2) has been identified to play an important role in the HLA-associated diseases and immune response. The goal of our meta-analysis was to summarize the contribution of TAP2 polymorphisms to the risk of RA.
Background
Rheumatoid arthritis (RA) is a common immune-mediated chronic inflammatory disease [1] . Severe clinical symptoms of RA comprise bone lose [2] and heart diseases [3] that can make a huge destruction to human body. RA is a complex disease caused by both genetic and environmental factors. Twin studies estimated a large heritability (60%) in RA [4] . Family-based studies also demonstrated that genetic factors played a more important role in the development of RA than environmental factors [5, 6] .
Consistent association was found between human leukocyte antigen (HLA) loci and RA [7] . The transporter associated with antigen processing 2 (TAP2) gene encodes transporter 2, ATP-binding cassette, sub-family B (MDR/ TAP) that is a major histocompatibility complex (MHC) gene located between HLA-DP and HLA-DQ [8] . TAP2 delivers antigenic peptides to the endoplasmic reticulum of HLA class I molecular [9] , especially in selecting the size of peptides [10] . TAP2 has been shown to play an important role in the HLA-associated diseases and immune response [11] .
TAP2 polymorphisms have been tested for their association with the occurrence and development of RA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Among them, Ile379Val, Ala565Thr and Thr665Ala are most often studied [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Altogether there were 10 case-control studies for the TAP2 polymorphisms with RA, yielding only 2 significant results (Table 1) . We suspected that a lack of power in the previous studies with moderate sample size might influence the reliability of the results [24] . Meta-analysis is often used to enhance statistical power and thus is likely to produce a more convincing conclusion [25] . Here we performed a set of meta-analyses of the three polymorphisms by pooling up the data from individual association study [25] . Our research is likely to provide a better evaluation of the contribution of TAP2 polymorphisms to the risk of RA.
Methods
We collected studies that examined the associations of TAP2 polymorphisms with RA in September of 2013 by searching the online databases (PubMed, WanFang, WeiPu and CNKI) without time and language restriction, using the keywords "rheumatoid arthritis TAP2 association" and "rheumatoid arthritis TAP2 polymorphism". The obtained studies would be included in our meta-analyses if they met the following criteria: (1) It was an original case-control study with an assessment of the association of TAP2 with RA in humans; (2) It contains sufficient information to infer the odds ratios (ORs) and 95% confidence intervals Since some studies presented the data of haplotypes (A to H, Table 2 ), our study translated the haplotypes into [28] were used to calculate statistical heterogeneity. Fixed-effect model would be used to the studies with minimal to moderate heterogeneity (I 2 < 50%), and the random-effect model would be used to the studies with significant heterogeneity (I 2 > =50%). Combined ORs and CIs were estimated by Review Manager 5 [29] . Funnel plots were drawn to observe the potential publication bias. The power of each study was calculated by Power and Sample Size Calculation program. All the statistical analyses were performed by two independent reviewers (Ping Ru and Xingyu Zhou).
Results and discussion
As shown in Figure 1 , 22 genetic studies on TAP2 gene were initially collected. Of them, we excluded 7 studies that were not related to RA, 1 case-only study, 4 studies without genotyping information, 1 study that did not meet HWE. Finally, 9 articles [14] [15] [16] [17] [18] [19] [20] [21] [22] were involved in the current study. Altogether, there were 973 RA patients and 965 controls in the meta-analyses of 3 TAP2 polymorphisms (Tables 1 and 3) .
In the present study, we tested the associations between 3 TAP2 polymorphisms and RA disease. Different inheritable models, including dominant, recessive and additive models, were also tested for all 3 polymorphisms. As shown in Table 3 and Figure 2 , a significant association of TAP2-379Ile with increased risk of RA was found for combined population (p = 0.0002, OR = 1.40, 95% CI = 1.16-1.70). Subgroup analysis by ethnicity showed that this significant association was only found in Asians (p = 0.03, OR = 1.38, 95% CI = 1.04-1.83, Table 3 and Figure 2 ) but not in Europeans (p = 0.16, Table 3 ). In addition, significant contribution of TAP2-379Ile to RA was only found in the dominant model (p = 0.006, OR = 1.59, 95% CI = 1.14-2.22, Table 3, Figure 2 ). For TAP2-565Thr, there was no significant result in the combined populations (p = 0.28, Table 3 ), but we found significant association between Europeans and RA (p = 0.002, OR = 1.62, 95% CI = 1.20-2.20, Table 3, Figure 2 ). For TAP2-665 locus, no significant result was found in the combined meta-analyses or in the subgroup meta-analyses (Table 3) .
Significant statistical heterogeneity was found in the meta-analyses of TAP2-565 (I 2 = 64%). A further subgroup meta-analyses by ethnicity showed that significant heterogeneity was coming from the Europeans for TAP2-379 (I 2 = 64%) and Asians for TAP2-565 (I 2 = 76%). Further subgroup studies showed that significant heterogeneity also existed in the meta-analyses of TAP2-565 (recessive model: I 2 = 64%; additive model: I 2 = 64%) and TAP2-665 (dominant model: I 2 = 67%, recessive model: I 2 = 77%; additive model: I 2 = 83%). All the power analyses in current meta-analyses were tested under a moderate risk of SCZ (OR = 1.2, Tables 1  and 2 ). Compared with previous individual studies, our meta-analyses showed a much stronger power (Tables 1  and 3 ). In addition, no publication bias for the metaanalyses was observed (Figure 3) .
To our knowledge, our study was the first meta-analyses of the three coding polymorphisms of TAP2 gene. Previous studies showed significant association between TAP2 gene and autoimmune diseases such as allergic rhinitis [30] , systemic lupus erythematosus [31] and RA [20, 21] . Our results indicated that TAP2-379Ile was able to increase 44% of the risk of RA in all subjects and 38% of the risk of RA in Asians. Moreover, TAP2-379Ile was associated with a 59% increased risk of RA in the dominant model. We also found that TAP2-565Thr increased the risk of RA by 62% in Europeans.
Previous RA association studies observed a handful of single nucleotide polymorphisms (SNPs) with dominant effect such as -607A/C polymorphism of IL-18 gene [32] , rs10489629 of IL-23R gene [33] , −173G/C polymorphism of MIF gene [34] and -607A/C polymorphism of IL-18 gene [32] . Our observation of significant association of TAP2-379Ile polymorphism in the dominant model supported that dominant model might be a key genetic model in the pathogenesis of RA disease.
Since MAFs are different in different populations, we further evaluated the role of TAP2 polymorphisms in Asians and Europeans separately. For TAP2-379Ile, significant association was found in Asians but not in Europeans. On the contrary, we observed TAP2-565Thr as a risky factor of RA in Europeans but not in Asians. This might be due to a lack of power in the subgroup meta-analysis in Europeans for TAP2-379 (power = 0.286, I 2 = 64%) and in Asians for TAP2-565 (power = 0.254, I 2 = 76%). To be noted, one Asian study [21] involved in the meta-analyses of TAP2-665Ala was found a high allele frequency (allele frequency = 0.601, Table 1 ) than those in the rest studies (average allele frequency = 0.284).
Our meta-analyses presented several limitations that needed to be taken with cautions. Firstly, the associations of TAP2 polymorphisms were only evaluated in Europeans and Asians. The findings might not be feasible for other populations such as Africans. And potential difference in intra-European and intra-Asian population might influence the result of our study (see the MAFs in Table 1 ). Secondly, RA is a complex chronic disease. Different clinical variables may influence the results of the current study. Hidden physiological factors may exist in the RA patients and affect the quality of the current meta-analysis. Further studies with precise diagnosis might be helpful for a better meta- analysis in the future. Thirdly, although the power of current meta-analyses was much stronger than the previous studies, more replicated studies are required to strengthen the stability of the association between TAP2 polymorphisms and RA. Fourthly, certain multiple testing existed in the current study, and cautions needed to be taken for the significant results. Fifthly, there are 2232 polymorphisms in TAP2 gene according to the NCBI dbSNP database. Our study only focused on three polymorphisms of TAP2 that might be hard to give fully consideration of the contribution of TAP2 polymorphisms. Moreover, the 3 TAP2 polymorphisms might not be the causal variants but be in high linkage disequilibrium with other established RA MHC variants. Sixthly, since significant associations were found in the both allelic and dominant model for TAP2-379, our results implied the genetic models of TAP2-379 polymorphism were complex and hard to be determined. Seventhly, there were publication biases for the current meta-analyses of TAP2-379 and TAP2-565. After removing the outlier studies [16, 17] , the results of the two meta-analyes remained the same as the previous one.
Conclusions
In summary, our meta-analyses suggested that TAP2-379Ile allele was significantly associated with a 59% increased risk in the dominant model. To be more specifically, TAP2-379-Ile increased the risk of RA by 38% in Asians and TAP2-565Thr increased the risk of RA by 38% in Europeans. Future large-scale and well designed studies are required to confirm our findings and to reveal other TAP2 polymorphisms with contribution to RA disease.
Abbreviations RA: Rheumatoid arthritis; SNPs: Single nucleotide polymorphisms; HWE: Hardy-Weinberg equilibriu; ORs: Odds ratios; 95% CIs: 95% confidence intervals.
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